Stock NVCT NUVECTIS PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Nuvectis Pharma, Inc.

Equities

NVCT

US67080T1088

Market Closed - Nasdaq
Other stock markets
 01:30:00 11/06/2024 am IST 		5-day change 1st Jan Change
6.53 USD +3.00% Intraday chart for Nuvectis Pharma, Inc. -0.15% -21.70%
07/05 Nuvectis Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
08/04 Nuvectis Pharma's Nxp900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines CI

Evolution of the average Target Price on Nuvectis Pharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

22850fc8019fe35.DnXv0kUwgIWmwQABfv5GAaJ5cjqcGkV-DYiQ7Ahg47I.SieugClW99PulkJWCIcNS9cmQAzPVgMRP-vejnsF1vVAGbe7CW_T3PSDbw~05b14e228d3cfe88eccf1d53bd4dabac

Analyst Recommendations on Nuvectis Pharma, Inc.

Ladenburg Thalmann Initiates Nuvectis Pharma at Buy with $21 Price Target MT
HC Wainwright Initiates Nuvectis Pharma at Buy With $14 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.34 USD
Average target price
22 USD
Spread / Average Target
+247.00%
High Price Target
25 USD
Spread / Highest target
+294.32%
Low Price Target
20 USD
Spread / Lowest Target
+215.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Nuvectis Pharma, Inc.

Ladenburg Thalmann
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NVCT Stock
  4. Consensus Nuvectis Pharma, Inc.